Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5179995011 | Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5179996012 | Product containing precisely leuprorelin (as leuprorelin acetate) 5 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5179997015 | Leuprolide (as leuprolide acetate) 5 mg prolonged-release subcutaneous implant | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant | Is a | Leuprorelin only product in parenteral dose form | true | Inferred relationship | Some | ||
| Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant | Has manufactured dose form | Prolonged-release subcutaneous implant | true | Inferred relationship | Some | ||
| Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant | Has unit of presentation | Implant (unit of presentation) | true | Inferred relationship | Some | ||
| Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant | Has precise active ingredient | Leuprorelin acetate | true | Inferred relationship | Some | 1 | |
| Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant | Has basis of strength substance (attribute) | Leuprorelin (substance) | true | Inferred relationship | Some | 1 | |
| Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant | Has presentation strength denominator unit (attribute) | Implant (unit of presentation) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR